{"id":"W1911381531","doi":"10.1111/apt.13432","title":"Miravirsen dosing in chronic hepatitis C patients results in decreased micro<scp>RNA</scp>‐122 levels without affecting other micro<scp>RNA</scp>s in plasma","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"Cilag; Alnylam Pharmaceuticals; Gilead Sciences; Janssen Research and Development; Innogenetics; Novartis; MedImmune; Roche; AbbVie; Merck; Bristol-Myers Squibb","keywords":"Medicine; Dosing; Placebo; Internal medicine; Gastroenterology; Chronic hepatitis; RNA; microRNA; Immunology; Pharmacology; Virus; Pathology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003539029,0.000413898,0.0008236632,0.0001716123,0.0001686513,0.0002963241,0.0002174596,0.0004802503,0.002102694],"category_scores_gemma":[0.0005368177,0.0002946772,0.000278509,0.0001678684,0.000453059,0.0002694722,0.0001443887,0.0007551677,0.0004024436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002031628,"about_ca_system_score_gemma":0.0002414862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001743545,"about_ca_topic_score_gemma":0.0003734793,"domain_scores_codex":[0.9997962,0.00006065827,0.00002302838,0.0000431825,0.00003843779,0.00003848393],"domain_scores_gemma":[0.9996206,0.0000753969,0.0001415012,0.0000272638,0.00001842702,0.0001168721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2105876,0.01540778,0.01957691,0.0005043981,0.0003341284,0.0002187706,0.000193213,0.0008858277,0.6844769,0.00007142658,0.0006877939,0.06705531],"study_design_scores_gemma":[0.04312308,0.7010223,0.1407741,0.00006676734,0.0002917869,0.001181035,0.000141799,0.001564173,0.1094829,0.0001383099,0.002162419,0.0000513141],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993087,0.000342478,0.00007312059,0.00002767062,0.00001479805,0.00004233046,0.00004761893,0.0000121469,0.0001311513],"genre_scores_gemma":[0.9986472,0.0002408538,0.0004367534,0.00005136987,0.00002415993,0.0000780535,0.0001240757,0.000003773857,0.0003938434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002102694,"threshold_uncertainty_score":0.007034242,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02910347638518196,"score_gpt":0.3047417585793402,"score_spread":0.2756382821941583,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}